Business Description
MustGrow Biologics Corp
NAICS : 325320
SIC : 3729
ISIN : CA62822A1030
Share Class Description:
FRA:0C0: Ordinary SharesTotal Employee Number:
8Compare
Compare
Traded in other countries / regions
MGRO.Canada0C0.GermanyMGROF.USA IPO Date
2019-09-30Description
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -11.57 | |||||
Beneish M-Score | 4.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -4 | |||||
3-Year EPS without NRI Growth Rate | -1.8 | |||||
3-Year FCF Growth Rate | -12.1 | |||||
3-Year Book Growth Rate | -47.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 67.37 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.88 | |||||
9-Day RSI | 50.52 | |||||
14-Day RSI | 48.45 | |||||
3-1 Month Momentum % | -9.64 | |||||
6-1 Month Momentum % | -19.79 | |||||
12-1 Month Momentum % | -41.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.73 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 155.42 | |||||
Days Sales Outstanding | 29.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.8 | |||||
Shareholder Yield % | -6.47 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.95 | |||||
Operating Margin % | -122.43 | |||||
Net Margin % | -150.83 | |||||
EBITDA Margin % | -138.31 | |||||
FCF Margin % | -82.08 | |||||
OCF Margin % | -82.08 | |||||
ROE % | -620.62 | |||||
ROA % | -138.48 | |||||
ROIC % | -442.85 | |||||
3-Year ROIIC % | 72.26 | |||||
ROC (Joel Greenblatt) % | -1066.62 | |||||
ROCE % | -280.9 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.04 | |||||
PB Ratio | 20.65 | |||||
Price-to-Tangible-Book | 25.8 | |||||
EV-to-EBIT | -4.31 | |||||
EV-to-Forward-EBIT | -6.27 | |||||
EV-to-EBITDA | -4.34 | |||||
EV-to-Forward-EBITDA | -6.34 | |||||
EV-to-Revenue | 6 | |||||
EV-to-Forward-Revenue | 6.13 | |||||
EV-to-FCF | -7.47 | |||||
| Price-to-Net-Current-Asset-Value | 25.8 | |||||
Earnings Yield (Greenblatt) % | -23.2 | |||||
FCF Yield % | -13.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MustGrow Biologics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.891 | ||
| EPS (TTM) (€) | -0.07 | ||
| Beta | 0.0474 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.7 | ||
| Volatility % | 55.54 | ||
| 14-Day RSI | 48.45 | ||
| 14-Day ATR (€) | 0.034458 | ||
| 20-Day SMA (€) | 0.2582 | ||
| 12-1 Month Momentum % | -41.18 | ||
| 52-Week Range (€) | 0.206 - 0.582 | ||
| Shares Outstanding (Mil) | 70.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MustGrow Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MustGrow Biologics Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
MustGrow Biologics Corp Frequently Asked Questions
What is MustGrow Biologics Corp(FRA:0C0)'s stock price today?
The current price of FRA:0C0 is €0.26. The 52 week high of FRA:0C0 is €0.58 and 52 week low is €0.21.
When is next earnings date of MustGrow Biologics Corp(FRA:0C0)?
The next earnings date of MustGrow Biologics Corp(FRA:0C0) is .
Does MustGrow Biologics Corp(FRA:0C0) pay dividends? If so, how much?
MustGrow Biologics Corp(FRA:0C0) does not pay dividend.
Press Release
Articles on MustGrow Biologics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers